Queen's Birthday Honour for Professor Richard Scolyer

 Queen's Birthday Honour for Professor Richard Scolyer

13 June 2021

Melanoma Institute Australia Co-Medical Director and Professor at The University of Sydney, Professor Richard Scolyer, has been recognised in the 2021 Queen’s Birthday Honours List announced today by the Governor-General.

Professor Scolyer has been appointed as an Officer (AO) of the Order of Australia (General Division) for distinguished service to medicine, particularly in the field of melanoma and skin cancer, as a clinician, researcher and educator, and to national and international professional organisations.

Professor Scolyer, born and raised in Launceston, is the world’s most published scientist in the field of melanoma pathology. For two decades he has been at the forefront of virtually all major advances in melanoma, resulting in vast improvements in survival of melanoma patients.

‘Professor Scolyer’s pioneering research, underpinned by his talent, passion and determination, has changed the face of melanoma diagnosis, treatment and survival, and saved many thousands of lives from melanoma,’ said fellow MIA Co-Medical Director, Professor Georgina Long AO.

‘Less than a decade ago, advanced melanoma was an almost certain death sentence, but thanks in no small part to Professor Scolyer’s ground-breaking research and diagnostic breakthroughs we are now steadfast on a course towards reaching zero deaths from this insidious disease.’

Each year, Professor Scolyer receives more than 2,000 of the most difficult cases from around the world for review and diagnosis.

He co-leads MIA, the world’s largest melanoma research and treatment facility, as well as the world-renowned translational research laboratory at The University of Sydney with his colleague and long-time friend Professor Long AO. He is also a senior specialist at Royal Prince Alfred Hospital & NSW Health Pathology.

‘It is a proud day for all of us at Melanoma Institute Australia who see first-hand Professor Scolyer’s life-saving contribution to cancer diagnosis and treatment,’ said MIA CEO Matthew Browne. ‘His inclusion in today’s Queen’s Birthday Honours List could not be more well deserved,’ he added.

Professor Scolyer has co-authored more than 700 peer reviewed publications/book-chapters including in prestigious journals such as New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer Discovery and has presented on more than 370 occasions at conferences throughout the world.

Professor Scolyer’s Queen’s Birthday Honour follows numerous awards including being named the 2020 Outstanding Researcher of the Year at the NSW Premiers Awards for Outstanding Cancer Research, and receiving the Royal College of Pathologists of Australasia (RCPA) Distinguished Fellow Award 2020The University of Sydney’s 2020 Alumni Award for International Achievement and being named the Clarivate Web of Science Group “Highly Cited Researcher 2020”. 

Despite his global research and clinical leadership, Professor Scolyer remains firm in his belief that the huge advances in melanoma treatment are a true team effort.

‘We have an amazing team of people doing world leading melanoma research and it’s a huge honour to be leading that team and to be recognised in this way,’ Professor Scolyer said.

‘Every cancer patient ultimately has their cancer diagnosed by a pathologist; what we see down the microscope and our research breakthroughs determine how a patient is treated and managed. Our research provides opportunity not only to benefit a single patient, but to make a difference to many thousands of patients for years to come, and that is what continues to drive us all.’

MIA CEO Matthew Brown commented: "The recognition of Richard completes an extraordinary quartet of honours awarded to the current and most recent medical directorship of MIA. A/Prof Jon Stretch AM (2012), Prof John Thompson AO (2014), Prof Georgina Long AO (2020) and now Prof Richard Scolyer AO (2021). MIA is truly fortunate that its mission has been and continues to be steered by such eminent Australians."

Australia has the highest melanoma rates in the world, with one person diagnosed with the disease every 30 minutes. 1300 Australians are expected to die from the disease this year. Melanoma is also the most common cancer impacting 15 to 39-year-olds.

 

Watch Prof Scolyer speaking about this achievement on #9News:

 

For more information, please contact:

Jennifer Durante - Melanoma Institute Australia - Ph 0412 798 990 Email: jennifer.durante@melanoma.org.au

Emma Betts' legacy will live on
17 May 2019

Emma Betts' legacy will live on

“I’m the age Emma was when she passed away. It almost feels unfair, that she has to not be here for me to be able to do this. But I will use this opportunity to push as hard as I can to reach our collective goal of zero deaths from melanoma.”

Support PBS listing for three adjuvant treatments of resected Stage III melanoma
13 May 2019

Support PBS listing for three adjuvant treatments of resected Stage III melanoma

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

Support PBS listing for pembrolizumab
06 May 2019

Support PBS listing for pembrolizumab

As always, part of the PBAC process invites clinicians, patients and other stakeholders in the cancer community to make submissions in support of the PBS listing.

How are the Premier's Awards helping cancer researchers?
02 May 2019

How are the Premier's Awards helping cancer researchers?

MIA had four winners in the 2017 Premiers Awards. Find out how winning has influenced their work over the past year.

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects
19 Mar 2019

Cancer Council awards Melanoma Institute Australia researchers funding for ground-breaking cancer research projects

Almost $9 million of new funding was awarded to 13 ground-breaking cancer research projects at the 2019 Cancer Council NSW Research Awards.

Making a difference to many
15 Mar 2019

Making a difference to many

Georgina V. Long is co-medical director of Melanoma Institute Australia and Chair of Melanoma Medical Oncology and Translational Research. She is the first woman president of the Society for Melanoma Research.

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March
26 Feb 2019

Aussie icon Sophie Monk calls on Australians to get behind Melanoma March

Quintessential Aussie girl and media personality Sophie Monk has been announced as a National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

Melanoma breakthrough paves way for personalised treatment for all cancer patients
14 Feb 2019

Melanoma breakthrough paves way for personalised treatment for all cancer patients

Australian researchers have for the first time identified specific cells and receptors in the immune system which predict how a patient will respond to treatment with immunotherapies, potentially paving the way for the development of personalised therapy for all cancer patients.

Melanoma March announces 2019 Principal Partner
07 Feb 2019

Melanoma March announces 2019 Principal Partner

Melanoma March is thrilled to introduce Ricky as our official Principal Partner for 2019!

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma
05 Feb 2019

Swimming champion Cate Campbell spearheads national campaign to save lives from melanoma

World record holder, Olympian and Australian swimming champion Cate Campbell has been announced as National Ambassador for Melanoma Institute Australia (MIA) and its national awareness and fundraising campaign, Melanoma March.

MIA experts collaborate on groundbreaking research
16 Jan 2019

MIA experts collaborate on groundbreaking research

MIA's expertise was essential to a recent Nature publication spearheaded by Perth’s Telethon Kids Institute and The University of Melbourne.

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA
20 Dec 2018

World-leading pathologist Associate Professor Michael Tetzlaff visits MIA

MIA is delighted to be hosting the MD Anderson pathologist on his first ever trip to Australia.

Possible PBS listing for dabrafenib and trametinib
18 Dec 2018

Possible PBS listing for dabrafenib and trametinib

Clinicians, patients and other stakeholders in the cancer community are invited to make submissions in support of the PBS listing for dabrafenib and trametinib.

Arden Anglican School wins SunSafe Ambassador competition
13 Dec 2018

Arden Anglican School wins SunSafe Ambassador competition

Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award.

DON'T CLOUD THE SUN-SAFE MESSAGE
08 Dec 2018

DON'T CLOUD THE SUN-SAFE MESSAGE

Mark Whittaker’s ‘Here comes the sun; Defending our summer rays’ (GW 24 Nov) clouds the sun-safe message – which could have disastrous consequences.

Professor Georgina Long named as one of world's most highly cited researchers
04 Dec 2018

Professor Georgina Long named as one of world's most highly cited researchers

Professor Georgina Long is among only 12 researchers from the University of Sydney to be named in the 2018 Highly Cited Researchers List.

Aussies need to protect themselves from 'everyday' sun damage
01 Dec 2018

Aussies need to protect themselves from 'everyday' sun damage

‘Wearing sunscreen should be as automatic as wearing a seatbelt. Both are potential life savers.

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma
29 Nov 2018

The Poche Centre to host 3D total-body imaging system as part of world-first initiative to save lives from melanoma

A prestigious $10 million Australian Cancer Research Foundation grant has been awarded to ACEMID, an initiative that aims to use 3D total-body imaging and a remote medicine network to improve the detection and diagnosis of early-stage melanoma.

Major award for world-leaders in melanoma research
09 Nov 2018

Major award for world-leaders in melanoma research

Professor Georgina Long and Professor Richard Scolyer have been recognised as world leaders in melanoma research for their ground-breaking work that has changed the diagnosis and treatment landscape of melanoma world-wide, and tripled the life-expectancy of advanced melanoma patients. 

Melanoma Institute Australia shines at prestigious Cancer Research Awards
03 Nov 2018

Melanoma Institute Australia shines at prestigious Cancer Research Awards

Leading researchers from Melanoma Institute Australia have taken out the top accolades at the NSW Premier’s Awards for Outstanding Cancer Research.